The introduction of immune-modulators (anti-TNF-α) and delayed T-cell recovery post transplantation (e.g., cord blood transplants/haplo-identical transplants) will likely increase the haematology population at risk of PcP [43]. This evidence concerns the gene TNF and pneumocystosis.